ArticleJournal for immunotherapy of cancer2019

Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer.

Christina A Hartl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.